NEW YORK (GenomeWeb News) – Gen-Probe and Affymetrix presented updates on their businesses for investors at the Thomas Weisel Healthcare Conference being held this week in Boston.

Gen-Probe officials said that the firm is on track with clinical trials for its Aptima HPV assay and expects to file for US Food and Drug Administration clearance of the test by the end of 2010. They also said that Panther, Gen-Probe's fully automated molecular instrument, is on schedule for a late 2010 launch in Europe, followed by a US launch in 2011.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: GWAS links gene to noise-induced hearing loss in mice, population genetics of malaria parasites, and more.

Nautilus' Alexandra Ossola examines how Tay-Sachs disease jump-started the genetic disease testing field.

FASEB says guidelines proposed by the NIH to bolster research reproducibility are premature and don't take the full range of scientific studies into consideration.

Liquid biopsies and DNA tests may be able to tell physicians whether a cancer patient is relapsing, the New York Times reports.

Apr
29
Sponsored by
Covance

This online seminar will review case studies demonstrating the clinical utility of CTCs and cfDNA to define and characterize a variety of dynamic genomic changes throughout the course of cancer detection and treatment.